Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Zijin Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2747-8373; OpenAlex author ID A5090571120. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 4

  1. Tumor cell-derived HSP47 promotes pancreatic Cancer metastasis via Homotrimeric collagen-mediated M2 macrophage polarization. Co-author DOI 10.1016/j.cellsig.2026.112589↗
  2. Construction of S100 family members prognosis prediction model and analysis of immune microenvironment landscape at single-cell level in pancreatic adenocarcin… Co-author DOI 10.1097/js9.0000000000001293↗
  3. Abrogation of KLF5 sensitizes BRCA1-proficient pancreatic cancer to PARP inhibition. Co-author DOI 10.3724/abbs.2023288↗
  4. Identification of characteristic markers correlated with Th2 cell infiltration and metabolism molecular subtype in pancreatic adenocarcinoma. Co-author DOI 10.21037/jgo-22-333↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenquan Wang · 3 shared papers, 2022–2024 · strength 0.65
  2. Xinxin Ling · 1 shared paper, 2026 · strength 0.29
  3. Qiongzhu Dong · 1 shared paper, 2026 · strength 0.29
  4. Jinbin Jia · 1 shared paper, 2024 · strength 0.23
  5. Liang Liu · 1 shared paper, 2024 · strength 0.23
  6. Zheng Zhang · 1 shared paper, 2024 · strength 0.23
  7. Yun Jin · 1 shared paper, 2024 · strength 0.23
  8. Pengcheng Li · 1 shared paper, 2022 · strength 0.22
  9. Liang Liu · 1 shared paper, 2022 · strength 0.22
  10. Jianang Li · 1 shared paper, 2024 · strength 0.20
  11. Liang Liu · 1 shared paper, 2024 · strength 0.20
  12. Huaxiang Xu · 1 shared paper, 2024 · strength 0.20
  13. Yuquan Guo · 1 shared paper, 2024 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.